Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158171 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
NCT00158171: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00158171 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 128 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00158171, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
Study Summary
Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
Interventions
- DRUG Nicotine patch
- DIETARY_SUPPLEMENT Folic Acid
- DRUG Nicotine Replacement Therapies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-05 |
| Phase | Phase 2 |
What the finished NCT00158171 record still lists
NCT00158171 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Nicotine patch is the first listed.
NCT00158171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00158171 about?
NCT00158171 is a clinical study titled "Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1". Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine g...
What is the current status of trial NCT00158171?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2002-04. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00158171?
The interventions under investigation include: Nicotine patch (DRUG), Folic Acid (DIETARY_SUPPLEMENT), Nicotine Replacement Therapies (DRUG).
Who is sponsoring clinical trial NCT00158171?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00158171's enrollment target sits among peer trials
128 553rd of 2000 higher than 1,446 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia